Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis

The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart(®) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) β-1a (Rebif(®)). The aim of the study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández, O., Arroyo, R., Martínez-Yélamos, S., Marco, M., Merino, J. A. García, Muñoz, D., Merino, E., Roque, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985132/
https://www.ncbi.nlm.nih.gov/pubmed/27526201
http://dx.doi.org/10.1371/journal.pone.0160313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985132/
https://www.ncbi.nlm.nih.gov/pubmed/27526201
http://dx.doi.org/10.1371/journal.pone.0160313

Ejemplares similares